share_log

復宏漢霖:自願公告 - 漢斯狀(斯魯利單抗注射液)聯合貝伐珠單抗注射液聯合化療一線治療轉移性結直腸癌(mCRC)的國際多中心3期臨床研究完成日本首例患者給藥

HENLIUS: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT IN JAPAN HAS BEEN DOSED IN AN INTERNATIONALMULTICENTRE PHASE 3 CLINICAL STUDY OF HANSIZHUANG (SERPLULIMAB INJECTION) IN COMBINATION WITH BEVACIZUMAB INJECTION AND CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATI

HKEX ·  Oct 24 17:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more